| Literature DB >> 36080308 |
Nurmaziah Mohammad Shafie1, Raja Nazatul Izni Raja Shahriman Shah1, Puspawathy Krishnan1, Noorashikin Abdul Haleem1, Terence Yew Chin Tan1.
Abstract
Wound healing is a natural process to restore damaged tissues due to loss of tissue integrity. Moringa oleifera (locally known as merunggai in Malaysia) has been traditionally used in various ailments, including for wound management. To evaluate the wound healing properties in M. oleifera, publications were searched and selected following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement with predetermined inclusion criteria. The databases searched for primary studies include PubMed, Google Scholar, Science Direct, LILACS, ClinicalTrials.gov, and CENTRAL. In total, 18 in vivo studies were included, which involved the leaves, while the remaining 5 studies involved other plant parts tested on excision, incision, dead space, abrasion, and burn-induced wound models. All studies reported significant wound healing abilities. Most studies used different topical formulations of aqueous leaves extract. The accumulation of collagen content and underlying wound healing mechanism through antimicrobial, antioxidant, and anti-inflammatory activities may be contributed by its bioactive phytochemical content, which has the potential to accelerate the wound contraction, increase the rate of epithelialization, and protect tissues against oxidative damage. In conclusion, M. oleifera showed wound healing potential but further studies are warranted to determine the main bioactive phytocompounds and safety.Entities:
Keywords: Moringa oleifera; epithelialization; herbal medicine; merunggai; wound healing
Mesh:
Substances:
Year: 2022 PMID: 36080308 PMCID: PMC9457785 DOI: 10.3390/molecules27175541
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Preferred Reporting Items for Systematic reviews and Meta-Analyses.
Characteristics of included studies.
| Author, Year | Country | Plant Part | Types of Formulation/Extract | Animal Model |
|---|---|---|---|---|
| Akanji, 2015 [ | Nigeria | Leaves | Methanol | Matured Wistar albino rats |
| Sivaranjani, 2016 [ | India | Leaves | Aqueous | Male Wistar albino rats |
| Azevedo, 2018 [ | Brazil | Leaves | Aqueous | Diabetic induced adult Wistar rats |
| Chin, 2018 [ | Malaysia | Leaves | Aqueous | Diabetic induced Male Sprague Dawley rats |
| Muhammad, 2016 [ | Malaysia | Leaves | Aqueous | Diabetic induced male Wistar rats |
| Kumar, 2016 [ | India | Leaves | Aqueous | Male Swiss albino rats |
| Charde, 2011 [ | India | Leaves | Ethanol | Male Wistar albino rats |
| Hukkeri, 2006 [ | India | Leaves | Ethyl acetate and ethanol | Male Wistar rats |
| Rathi, 2006 [ | India | Leaves | Aqueous | Male Swiss albino rats |
| Islam, 2018 [ | Bangladesh | Leaves | Aqueous | Female Wistar rats |
| Agnes, 2014 [ | Philippines | Twig | Ethanol | Healthy Guinea pigs |
| Lambole, 2012a [ | India | Bark | Aqueous | Wistar albino rats |
| Lambole, 2012b [ | India | Bark | Aqueous and ethanol extract | Wistar albino rats |
| Rathi, 2004 [ | India | Fruits (pulp and seed) | Aqueous | Male albino rats |
| Amaliya, 2019 [ | Indonesia | Leaves | Ethanol | Male Sprague–Dawley rats |
| Ali, 2021 [ | India | Seeds | n-hexane | Swiss albino mice |
| Ayu, 2020 [ | Indonesia | Leaves | Not reported | Male Wistar rats |
| Natarajan, 2018 [ | Malaysia | Leaves | Aqueous | Diabetic induced male Wistar albino rats |
Data extraction table on wound healing activity.
| Author, Year | Mode | Dosage/Formulation | Comparison | Type of Wound | Findings |
|---|---|---|---|---|---|
| Akanji, 2015 [ | Topical | 100 mg/mL | Gentamycin (8 mg/mL) | Excision | Wound closure in the non-infected group was 61.0%, significantly higher compared to gentamycin (21.0%) on day 12th post wound. As for |
| Sivaranjani, 2016 [ | Topical | 0.5% ointment gel contained TiNPs developed using | Gel contained sulfadiazine | Excision | Wound closure was faster (92.36 ± 0.5%) compared to control (75.23 ± 0.58%) and standard drug (83.55 ± 0.57%) on day 12 post wound. ( |
| Azevedo, 2018 [ | Oral followed by topical | Oral: 100 mg/kg | Normal saline | Excision | Wound closure for both normal and diabetic induced rats were faster (92% and 88%, respectively) compared to control (61% and 64%, respectively) ( |
| Topical: 200 μL of 10% | |||||
| Chin, 2018 [ | Topical | 0.1%, 0.5%, 1.0% ( | Commercial dressing (Kaltostat) | Excision | Dose 0.5% ( |
| Abrasion | Wound closure was faster (81 ± 4.5%) compared to control (28.8 ± 9.85%) and commercial dressing (73.13 ± 8.05%) on day 3 post wound ( | ||||
| Muhammad, 2016 [ | Topical | 0.5, 1.0, and 2.0% ( | Silver sulfadiazine | Excision | The highest dose (2%) showed faster contraction rate from 59.7% on day 3 progressed to complete wound closure by day 21 compared to normal and diabetic control. The epithelialization period recorded in the aqueous fraction treated group was 11 ± 1 days compared to untreated diabetic control (15 ± 1 days). |
| Kumar, 2016 [ | Topical | Untreated wound | Excision | Wound closure was achieved by 14th day of treatment (99.3 ± 0.09%) compared to control (88.0 ± 0.54%) and the mean period of epithelization shorter (14.66 days) compared to control (17.16 days) ( | |
| Incision | Tensile strength was higher (507.5 ± 7.14 g) compared to control (367.5 ± 6.76 g) ( | ||||
| Charde, 2011 [ | Topical | Framycetine Sulphate Cream (FSC) | Excision | Wound closure was (98.52%) on day 27 post-wound compared to control (78.61%) and FSC (100%). The epithelialization showed higher similarity to normal tissues (4.06 ± 0.04) compared to control (1.23 ± 0.55) and comparable to FSC (4.16 ± 0.04) where value 5 refers to maximum similarity and 0 refers to least similarity. ( | |
| Incision | Tensile strength of extract and FSC were almost comparable with 320.51 ± 0.45 g and 365.41 ± 3.55 g, respectively. ( | ||||
| Dead space | Granuloma breaking strength for the extract was higher than control (315.67 ± 1.55 g, 278.89 ± 2.60 g, respectively) ( | ||||
| Hukkeri, 2006 [ | Topical ointment and oral | Topical: 10% ( | Vicco turmeric cream | Excision | Ethyl acetate extract significantly showed faster wound closure (99.87 ± 0.42%) than ethanol extract (99.69 ± 0.45%) comparable to Vicco turmeric cream (99.90 ± 0.32%) on day 14 post wound. ( |
| Oral | 300 mg/kg | Vicco turmeric cream | Incision | Ethyl acetate extract significantly showed higher tensile strength (473.80 ± 1.23) than control (241 ± 1.02) and ethanol extract (439.17 ± 1.11) respectively. ( | |
| Dead space | Granuloma studies showed the tensile strength of ethyl acetate extract was significantly higher (355.83 ± 0.89 g) compared to control (180.00 ± 0.98 g) and ethanol extract (345.00 ± 0.86 g) respectively. ( | ||||
| Rathi, 2006 [ | Oral | 300 mg/kg bw | 2% gum acacia | Excision | Almost complete wound closure achieved on day 16 post wound (99.92 ± 0.70%), faster than 2% gum acacia (83.52 ± 1.78%). Epithelialization period was significantly shorter compared to 2% gum acacia. ( |
| Incision | Tensile strength was significantly higher (358.50 g ± 8.03) compared to 2% gum acacia (282.66 g ± 0.24). ( | ||||
| Dead space | Tensile strength, hydroxyproline content, and granuloma weight were significantly higher (252.0 ± 6.54 g, 6.83 ± 0.13 µg/300 mg, and 45.61 ± 1.85 mg%, respectively) than 2% gum acacia (219.0 ± 5.70 g, 5.23 ± 0.20 µg/300 mg and 36.72 ± 1.90 mg%, respectively). ( | ||||
| Islam, 2018 [ | Topical | 2% extract | Untreated wound | Burn induced | Wound closure for AM+MO was the fastest (96 ± 1.96%) compared to control (43.45 ± 1.32%) on day 24 and showed shorter epithelialization period (19.6 days) compared to AM (23.2 days), MO (28.2 days) and control (31.4 days). ( |
| Agnes, 2014 [ | Topical | 5, 7.5, 10 mg/mL | Calmoseptine | Excision | Dose 10 mg/mL stimulated the wound healing property of the standard drug used. ( |
| Lambole, 2012a [ | Topical | 5% | 5% | Excision | Contrary with the DMS treated group, the extract showed complete wound closure on day 20 compared to control simple ointment (94.00 ± 0.44%), standard drug PIO (97.17 ± 0.5%), DMS injection (86.00 ± 0.57%) and extract treatment after DMS injection (95.50 ± 0.71%). |
| Incision | The wound breaking strength was significantly higher (556.30 ± 1.28 g) compared to control (388 ± 0.98 g), PIO (492 ± 2.37 g), and that prior injection with DMS. ( | ||||
| Dead space | The extract significantly increased the granuloma breaking strength (521.70 ± 2.47 g) and hydroxyproline content (65.03 ± 0.80 µg/mL) compared to control (262.20 ± 4.00 g and 33.63 ± 1.17 µg/mL, respectively). ( | ||||
| Lambole, 2012b [ | Topical | 5% | 5% ( | Excision | Aqueous extract showed the fastest wound contraction progress by 12th day with 90.17 ± 0.54% while ethanol extract was 88.17 ± 0.47% compared to PIO (65.17 ± 0.83%) and control (65.17 ± 0.83%). ( |
| Incision | Wound breaking strengths of aqueous extract was the best (556.3 ± 1.28 g) compared to ethanol extract (519.7 ± 1.28 g), PIO (492.8 ± 2.37 g) and control (388.3 ± 0.98 g). ( | ||||
| Dead space | Granuloma breaking strength of aqueous extract was higher (521.7 ± 2.47 g) compared to PIO (412.0 ± 5.85 g) and others. ( | ||||
| Rathi, 2004 [ | Oral | 300 mg/kg | 2% gum acacia | Excision | Extract significantly enhanced wound closure (15.0 ± 0.56 days), reduced mean scar area (27.66 ± 1.87 mm2) compared to 2% gum acacia as a control (18.5 ± 0.22 days and 42.33 ± 2.40 mm2, respectively). ( |
| Incision | Wound breaking strength was higher (360.50 ± 8.03 g) compared to control (279.66 ± 0.24 g). ( | ||||
| Dead space | Granuloma breaking strength (263.0 ± 6.54 g), hydroxyproline content (7.63 ± 0.13 µg/mg), and granuloma weight (0.140 ± 0.0214 g/100 bw) was higher compared to control (209.0 ± 5.70 g, 5.23 ± 0.20 µg/mg), and 0.017 ± 0.0035 g/100 bw, respectively). ( | ||||
| Amaliya, 2019 [ | Topical | 2% & 4% | Povidone iodine gel 10% | Excision (Palatal wound) | Enhanced wound closure and epithelialization that were shown through increased fibroblast synthesis and increased collagen deposition compared to control. |
| Ali, 2021 [ | Topical | 5% and 10% of | Control placebo carbopol hydrogel & standard 5% Povidone | Excision | Wounds healed up to 97% and 98% on day 12 using 5% and 10% hexane hydrogel as compared to standard which is healed by 82%. |
| Incision | Tensile breaking strength for both 5% hexane hydrogel and 10% hexane hydrogel (152 g and 156 g, respectively) were significantly higher compared to control (96 g) and standard (115 g). ( | ||||
| Ayu, 2020 [ | Topical | Not mentioned | Hydrogel | Incision | Epithelialization is significantly enhanced (57.94 ± 7.67 µm) compared to the control group (25.19 ± 3.31 µm) on day 11 post wound. ( |
| Natarajan, 2018 [ | Topical | 0.5%, 1.0%, 2.0% | Unclear as only ‘market sample’ is mentioned. | Excision | Wound closure was significantly higher (89.76%) compared to control (45.75%) and market sample (73.38%) on day 8 of treatment. ( |
Figure 2Risk of bias summary of included studies.
Figure 3Risk of bias assessment of included studies of M. oleifera for wound healing: Green for low risk of bias, yellow for unclear risk of bias and red for high risk of bias.